There Are Now 365 Studies that Prove the Efficacy of Ivermectin and HCQ in Treating COVID-19 — Will Anyone Confront Fauci and The Medical Elites on Their Deception?

There have now been 67 Ivermectin COVID-19 controlled studies that show a 67% improvement in COVID patients.

There have been 298 Hydroxychloroquine studies that show a 64% improvement in patients for COVID-19 patients.

Despite the science, Dr. Fauci and the medical elites have blocked the use of these effective treatments for coronavirus patients.

Dr. Robert Malone, the inventor of the mRNA vaccines, accused Dr. Fauci and others of lying and causing the death of over 500,000 Americans by preventing HCQ and Ivermectin, and other treatments from COVID-19 patients.

Dr. Malone is right.  It is well documented that Dr. Fauci and top US doctors conspired to disqualify and condemn hydroxychloroquine as a COVID-19 treatment.
Millions died as a result of this.

Keep reading

As Biden Became President, Medical Journal Quietly Retracted Study That Claimed Hydroxychloroquine Is Ineffective

A leading medical journal has issued a retraction of their endorsement for a study that concluded the anti-viral drug hydroxychloroquine was ineffective against the COVID-19 virus. This retraction appears to validate the claims then-President Trump made about the medication being a frontline drug in the battle in the pandemic.

The Lancet, a respected online medical journal, issued an apology to its readers in an edition last year after the retraction. “We deeply apologize to you, the editors, and the journal readership for any embarrassment or inconvenience that this may have caused,” the publishers of The Lancet said.

Compared to the significantly more expensive medications being used to treat the virus, hydroxychloroquine – a drug widely used to treat malaria – is relatively inexpensive and universally available. Hydroxychloroquine ranges in price from $0.30 to $6.63 per dose depending on location.

The Lancet’s endorsement of the study was withdrawn because the Surgisphere Corporation, the company that provided data, refused to provide full access to the information it based its study on. Peer review medical journals typically engage in third-party peer review to validate the findings.

The Surgisphere Corporation said it refused to release the study data because it would violate client agreements and confidentiality requirements, raising questions about the study’s legitimacy.

“Based on this development, we can no longer vouch for the veracity of the primary data sources. Due to this unfortunate development, the authors request that the paper be retracted,” The Lancet said in a statement.

In the now debunked study, researchers concluded that hydroxychloroquine didn’t aid in curbing the COVID-19 virus. It went on to say that the drug caused heart problems and appeared to elevate the risk of death.

Keep reading

Ivory Hecker Says Fox Corp Censored Bitcoin, Hydroxychloroquine, and Free Speech Stories

“There’s a narrative. Yes, it is unspoken. But if you accidentally step outside the narrative, if you don’t sense what that narrative is and go with it, there will be grave consequences for you… Fox came at my throat for standing up against censorship.” Hecker claimed in the bombshell interview. 

Other revelations in the video include audio of Fox 26’s Vice President and News Director, Susan Schiller, telling Hecker to “cease and desist posting about Hydroxychloroquine” on social media, and that she “failed as a reporter” for reporting about the drug. Schiller then mentioned a study from the New England Journal of Medicine to justify why she was not allowing Hecker to report on Hydroxychloroquine. 

The video also included an audio clip of a Fox official saying “it’s not just about the viewers, It’s about what our CEO reads.” 

Keep reading

Anthony Fauci Ignored Email from Physicist Claiming Hydroxychloroquine Could Help Battle Coronavirus

Emails show Dr. Anthony Fauci was advised by Erik Nielsen, a physicist and CEO of Bio-Signal Technologies, in March 2020, that two drugs could possibly help battle the coronavirus pandemic, but Fauci ignored it, claiming the email was “too long” for him to read.

Nielsen, in the email, said he had instructed members of his family to get “Alvesco (ciclesonide) for emergency use only.” He claimed that his “colleagues on the front-line in Japan, China, and Korea found several pre-print papers, that it is an effective treatment for late-stage COVID-19 patients.”

The physicist continued, “Some patients on ventilators who were approaching death have fully recovered after treatment with ciclesonide,” noting “ciclesonide has much smaller particles than other corticosteroids, so it reaches deeper into lungs and alveolis.”

Neilsen claimed there was a second drug that could possibly be used, which he advised his family to get. He wrote to Fauci the drug “is called hydroxychloroquine,” which he said, “also seems to be effective and safe.”

However, he noted, “Alvesco is better because it appears to prevent the virus from replicating so infection is wiped out and no longer contagious. Alvesco seems to be two silver bullets in one.”

Two days after this email, Fauci, to whom the media looked for a trusted voice, said,”The answer is no” when he was asked if hydroxychloroquine is an effective coronavirus treatment during one of the coronavirus task force briefings that took place regularly under the Trump administration. Fauci noted that the “signs of the drug’s promise were purely ‘anecdotal evidence.’”

Keep reading

SMOKING GUN: FAUCI LIED, MILLIONS DIED — Fauci Was Informed of Hydroxychloroquine Success in Early 2020 But Lied to Public Instead Despite the Science #FauciEmails

It’s been over a year since the WHO declared the coronavirus a pandemic after originally downplaying the threat.  It is no secret that both the disease and the response to combat it following this SARS-CoV-2 outbreak in late 2019 have turned our world upside-down.  Mandates, lockdowns, and guidelines seem to change every time Dr. Fauci opens his mouth.   All of these unprecedented rules were put into place, we were told, to slow down the spread of a disease that today is linked to the death of over half a million Americans and 3.7 million global citizens in the last year.

You would think that researchers would have concentrated on prophylactic and therapeutic solutions of this disease especially since this disease is a death sentence for the elderly, the obese, those with preexisting conditions.  The coronavirus doctors have forced children to avoid school, mask up, and get vaccinated.  One would think that after all this time there would be a consensus in the hospitals, in the nursing homes, and in other treatment centers on how to treat a Covid positive patient or resident.  This is not the case.

There still is no agreed-upon treatment plan for elderly patients who catch coronavirus to assist in their recovery.

The CDC and Dr. Fauci ignored treatment plans for coronavirus patients unless the person was under severe distress.

Keep reading

Docs urge early outpatient treatment for COVID-19

The year 2020 will have been marked by a series of studies on treatments against COVID-19 and associated controversies. All will remember the declarations of the Minister of Health and the Prime Minister that ”  there is no treatment against Covid-19  ” despite the studies published by the IHU of Prof. Raoult. In December, the Italian Council of State rehabilitated the early-phase treatment based on hydroxychloroquine, proving the doctors right and recalling the principle that no national agency should interfere in the privileged relationship between a doctor and his patient.

In the United States in October, under the influence of Senator Johnson , Professors Peter McCullough , Harvey Risch, and doctor Pierre Kory testified under oath to the Senate commission of inquiry into early stage treatments. The latter recalled the fundamental basis of a response to a viral epidemic with the 4 pillars: the control of contagion by various measures such as barrier gestures, early phase treatment, hospital care, and the vaccine or group immunity.

peer-reviewed study published in the Reviews of Cardiovascular Medicine (Reviews of Cardiovascular Medicine) on December 30, 2020 by a group of 57 doctors, including Dr. Peter McCullough and Dr. Harvey Risch, many of whom have treated the disease in the early phase, includes all the elements to show that there is no cure for Covid-19, but that a combination of drugs and other supplements can significantly reduce the risk of worsening the disease . This also leads to a reduction in hospitalization needs, thus reducing the pressure on the use of intensive care or resuscitation beds. The question of risk benefit for the need for a vaccine therefore arises.

Keep reading

‘Only a one in 17 billion chance hydroxychloroquine doesn’t work’: medical professor

Hydroxychloroquine really works says Professor of Medicine Dr Peter McCullough, describing the treatment as “the most widely used therapeutic” to treat COVID-19 in the world. “The chances that it doesn’t work are calculated to be one in 17 billion,” he told Sky News. “There’s no controversy over whether or not hydroxychloroquine works. The controversy is on the public health approach to COVID-19.” Mr McCullough said “the virus invades inside cells, so we have to use drugs that go inside the cell and work to reduce viral replication”. “The drugs that work within the cell and actually reduce viral replication are hydroxychloroquine, Ivermectin, doxycycline and azithromycin”. “Sadly, in the United States and I know in Australia this happens all the time, patients get no treatment whatsoever. They literally are told to stay at home until they are sick enough to go to the hospital”

Keep reading

Coronavirus deaths 75% lower in nations using hydroxychloroquine!

With media solemnly spotlighting the passing of the 200,000 mark in deaths attributed to COVID-19 in the United States, a physicians assocation has a question.

“Why is the death rate about 75 percent lower in many countries?” asked Dr. Jane Orient, executive director of the Association of American Physicians and Surgeons.

The reference is to a country-based analysis updated Sept. 20 that shows a gap between countries that treat COVID-19 early or prophylactically with hydroxychloroquine and those that, like the U.S., discourage or prohibit its use.

The answer to Orient’s question can be found in a white paper published by the Economic Standard this month titled “Hydroxychloroquine and the Burden of Proof: An Urgent Call to Depoliticize Medicine in the COVID-19 Pandemic.”

“The COVID-19 pandemic struck America nine months before a presidential election, turning basic medical activities like testing and treatment into partisan battlegrounds,” writes Economic Standard Editor-in-Chief Erik Sass in the overview. “No subject has been more distorted than hydroxychloroquine (HCQ), a safe, versatile medicine that has treated hundreds of millions of people for numerous diseases for seven decades.”

Keep reading